Wednesday, 12 December 2018

Improving understanding of biosimilars in the EU


The European Medicines Agency (EMA) and the European Commission have published additional information material on biosimilar medicines, as part of their ongoing collaboration to improve understanding of biosimilars across the European Union (EU). A biosimilar is biological medicine that is highly similar in all essential aspects to a 'reference' biological medicine already authorised.

See EMA - https://www.ema.europa.eu/news/improving-understanding-biosimilars-eu



Posted by Dr. Tim Sandle, Pharmaceutical Microbiology

No comments:

Post a Comment

Pharmaceutical Microbiology

Special offers